Works by Feng, Hwa-Ping


Results: 42
    1

    Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants.

    Published in:
    Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 952, doi. 10.1002/cpdd.702
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Fandozzi, Christine;
    • Panebianco, Deborah;
    • Caro, Luzelena;
    • Wolford, Dennis;
    • Dreyer, Daniel P.;
    • Valesky, Robert;
    • Martinho, Monika;
    • Rizk, Matthew L.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    2

    Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.

    Published in:
    Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 962, doi. 10.1002/cpdd.701
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Talaty, Jennifer E.;
    • Mangin, Eric;
    • Panebianco, Deborah;
    • Fandozzi, Christine;
    • Zhu, Yali;
    • Marshall, William;
    • Huang, Xiaobi;
    • Hanley, William D.;
    • Jumes, Patricia;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    3
    4
    5

    Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 643, doi. 10.1007/s00280-013-2240-8
    By:
    • Doi, Toshihiko;
    • Muro, Kei;
    • Yoshino, Takayuki;
    • Fuse, Nozomu;
    • Ura, Takashi;
    • Takahari, Daisuke;
    • Feng, Hwa-ping;
    • Shimamoto, Takashi;
    • Noguchi, Kazuo;
    • Ohtsu, Atsushi
    Publication type:
    Article
    6
    7
    8

    No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

    Published in:
    European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 593, doi. 10.1007/s00228-017-2216-4
    By:
    • Marshall, William;
    • Feng, Hwa-Ping;
    • Caro, Luzelena;
    • Talaty, Jennifer;
    • Guo, Zifang;
    • Huang, Xiaobi;
    • Panebianco, Deborah;
    • Ma, Joanne;
    • Mangin, Eric;
    • O'Reilly, Terry;
    • Butterton, Joan;
    • Yeh, Wendy
    Publication type:
    Article
    9
    10
    11

    No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.

    Published in:
    CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 562, doi. 10.1111/cts.12565
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Marshall, William L.;
    • Liu, Fang;
    • Panebianco, Deborah;
    • Vaddady, Pavan;
    • Barbour, April;
    • Reitmann, Christina;
    • Jumes, Patricia;
    • Gilmartin, Jocelyn;
    • Wolford, Dennis;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Fraser, Iain;
    • Webster, Lynn;
    • Yeh, Wendy W.
    Publication type:
    Article
    12

    No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.

    Published in:
    CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 553, doi. 10.1111/cts.12564
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Marshall, William L.;
    • Liu, Fang;
    • Panebianco, Deborah;
    • Vaddady, Pavan;
    • Reitmann, Christina;
    • Jumes, Patricia;
    • Wolford, Dennis;
    • Fraser, Iain;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Webster, Lynn;
    • Yeh, Wendy W.
    Publication type:
    Article
    13

    A pathogenic family business.

    Published in:
    Nature Structural Biology, 2002, v. 9, n. 7, p. 506, doi. 10.1038/nsb0702-506
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    14

    Tweezers with a light touch.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 12, p. 1013, doi. 10.1038/nsb1201-1013
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    15

    The X-ray files.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 10, p. 831, doi. 10.1038/nsb1001-831
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    16

    Acid test for viral fusion.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 8, p. 660, doi. 10.1038/90351
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    17

    A DNA acrobat.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 7, p. 583, doi. 10.1038/89607
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    18

    Gut-wrenching bugs.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 6, p. 487, doi. 10.1038/88538
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    19

    Reining in CDK.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 5, p. 391, doi. 10.1038/87542
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    20

    The separator.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 4, p. 301, doi. 10.1038/86163
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    21

    Getting started.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 2, p. 109, doi. 10.1038/84085
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    22

    A DNA wormhole.

    Published in:
    Nature Structural Biology, 2001, v. 8, n. 1, p. 20, doi. 10.1038/83000
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    23

    Milking it for all it's worth.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 12, p. 1090, doi. 10.1038/81927
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    24

    Catching rays.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 11, p. 1005, doi. 10.1038/80909
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    25

    A protein microarray.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 10, p. 829, doi. 10.1038/79570
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    26

    COX complexes.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 6, p. 448, doi. 10.1038/75840
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    27

    The power of atomic force.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 5, p. 354, doi. 10.1038/75115
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    28

    Freeze frame.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 4, p. 270, doi. 10.1038/74021
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    29
    30

    Picking pathways.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 2, p. 100, doi. 10.1038/72357
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    31

    Early cryo-EM work.

    Published in:
    Nature Structural Biology, 2000, v. 7, n. 1, p. 22, doi. 10.1038/71218
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    32

    Dimers can do the deed.

    Published in:
    Nature Structural Biology, 1999, v. 6, n. 10, p. 909, doi. 10.1038/13271
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    33

    Break up to act up.

    Published in:
    Nature Structural Biology, 1999, v. 6, n. 8, p. 720, doi. 10.1038/11481
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    34

    Mopping up histamine.

    Published in:
    Nature Structural Biology, 1999, v. 6, n. 7, p. 612, doi. 10.1038/10653
    By:
    • Feng, Hwa-ping
    Publication type:
    Article
    35
    36
    37

    Research Highlights.

    Published in:
    Nature Structural & Molecular Biology, 2006, v. 13, n. 2, p. 102, doi. 10.1038/nsmb0206-102
    By:
    • Feng, Hwa-ping;
    • Hodges, Maria;
    • Montoya, Michelle;
    • Schmidt, Tracy Smith
    Publication type:
    Article
    38

    Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.

    Published in:
    Clinical Drug Investigation, 2021, v. 41, n. 2, p. 133, doi. 10.1007/s40261-020-00974-8
    By:
    • Caro, Luzelena;
    • Prueksaritanont, Thomayant;
    • Fandozzi, Christine M.;
    • Feng, Hwa-Ping;
    • Guo, Zifang;
    • Wolford, Dennis;
    • Panebianco, Deborah;
    • Fraser, Iain P.;
    • Levine, Vanessa;
    • Swearingen, Dennis;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    39
    40
    41
    42